Lavish Lash
100/100
This product looks safe
- No ingredients exceed tolerable upper intake levels
- 64% of ingredients have research evidence
A
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Label Data
3 Tablet(s)
Serving Size
30
Servings
Other Combinations
Product Type
64%
Evidence Coverage
Supplement Facts — Evidence Check
Calcium
733 mg
(73% DV)
150 mg
(15% DV)
✅ Within RDA (0.2× RDA of 700 mg)
📚 12 studies (Tier A: 0, B: 3)
Vitamin C
120 mg
(200% DV)
100 mg
(25% DV)
📊 Market median: 4002.0mg (1 products)
📚 20 studies (Tier A: 0, B: 2)
25 mg
(125% DV)
✅ 1.8× RDA — within safe limits
📚 193 studies (Tier A: 5, B: 63)
15 mg
(150% DV)
✅ 3.0× RDA — within safe limits
📚 1 studies — no high-quality reviews
Sodium
10 mg
(1% DV)
7.5 mg
(50% DV)
✅ Within RDA (0.7× RDA of 11 mg)
📚 258 studies (Tier A: 6, B: 134)
5 mg
(333% DV)
📊 4.2× RDA — above typical dose
📚 76 studies (Tier A: 0, B: 33)
5 mg
(294% DV)
📊 2083.3× RDA — above typical dose
📚 138 studies (Tier A: 1, B: 44)
5 mg
(250% DV)
✅ 2.2× RDA — within safe limits
📚 8 studies — no high-quality reviews
5 mg
(250% DV)
📊 3.8× RDA — above typical dose (UL: 100 mg)
📚 113 studies (Tier A: 3, B: 35)
Iron
3 mg
(17% DV)
3000 mcg
(1000% DV)
📊 100.0× RDA — above typical dose
📚 26 studies (Tier A: 0, B: 11)
200 mcg
(50% DV)
✅ Within RDA (0.5× RDA of 0.4 mg)
📚 225 studies (Tier A: 10, B: 105)
112.5 mcg
(75% DV)
✅ Within RDA (0.8× RDA of 0.15 mg)
📚 243 studies (Tier A: 4, B: 133)
12.5 mcg
(18% DV)
✅ Within RDA (0.2× RDA of 0.055 mg)
📚 172 studies (Tier A: 0, B: 67)
8 mcg
(133% DV)
📊 3.3× RDA — above typical dose
📚 138 studies (Tier A: 1, B: 44)
Vitamin A
5000 IU
(100% DV)
100 IU
(25% DV)
✅ Within RDA (0.2× RDA of 0.015 mg)
📚 604 studies (Tier A: 16, B: 251)
15 IU
(50% DV)
✅ Within RDA (0.7× RDA of 15 mg)
📚 177 studies (Tier A: 3, B: 90)
Lash and Brow Growth Matrix
225.5 mg
Other Ingredients
Vegetable Cellulose
Label Claims — Verification
❓
All Other
❓
Structure/Function
All Other (99% of products)
Structure/Function (85% of products)
Nutrient (54% of products)
Approved Health (3% of products)
Target Groups
Adult (18 - 50 Years)
Women (not pregnant or lactating)
Product Information
📋 Directions for Use
Directions: Take three tablets once daily. Use for a minimum of at least 60 days as eyelashes and eyebrows are the slowest growing hairs on the human body. Best results can be seen after 90 days.
⚠️ Warnings & Precautions
Warning: Not intended for use by pregnant or nursing women or by any persons under the age of 18.
Warning: Not intended for use by pregnant or nursing women or by any persons under the age of 18. If you are taking any medications, consult your doctor or health care professional before use.
Discontinue use immediately if you experience any adverse reactions.
Keep this product out of reach of children.
In case of accidental overdose, call a doctor or poison control center immediately.
🧪 Formulation Notes
Eyelash and eyebrow growth supplement Promotes longer, fuller, looking lashes and brows
Product Details
UPC / SKU
8 6001 02940 6
DSLD Entry Date
2020-07-23
Product Type
Other Combinations
Form
Tablet or Pill
Brand
Hairgenics
DSLD ID
229573
Data Updated
2026-04-11
Research Evidence
849
Research Sources
56
Avg Quality Score
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
A
Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
A
Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
A
Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
A
Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
A
Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
A
Calcium and vitamin D for increasing bone mineral density in premenopausal women
A
Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
A
The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Compare Similar Products
Magnesium
Vitabase
100
Natural Magnesium 250 mg
Sunmark
100
Magnesium Taurate 400
Douglas Laboratories
100
Magnesium 250 mg USP
Equaline
100
Magnesium-Oxide
Genesis Products
100